Top Markets
#1 Black Phoenix Black Phoenix +166.76%
#2 Islamic Coin Islamic Coin +158.08%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +32.45%
#5 Cryptopia Cryptopia +21.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +18.20%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.17%
#9 DOVU DOVU +13.50%
#10 Test Test +13.48%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Rank in Stocks #41544
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Share Price
$0.0005
Last synced: 2026-08-11
Market Cap
$16.73K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade ARYx Therapeutics, Inc. (ARYX)

Category

Healthcare
Dividend history for ARYx Therapeutics, Inc. (ARYX)
ARYx Therapeutics, Inc. (stock symbol: ARYX) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for ARYx Therapeutics, Inc. (ARYX) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00%
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
38.00%
IN